Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
NCT00004861
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
gemcitabine hydrochloride
DRUG:
tacedinaline
Sponsor
Pfizer